These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 1282428

  • 1. Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements.
    Vuillier F, Claisse JF, Vandenvelde C, Travade P, Magnac C, Chevret S, Desablens B, Binet JL, Dighiero G.
    Leuk Lymphoma; 1992 Jun; 7(3):195-204. PubMed ID: 1282428
    [Abstract] [Full Text] [Related]

  • 2. Clonotypic polymerase chain reaction confirms minimal residual disease in CLL nodular PR: results from a sequential treatment CLL protocol.
    Noy A, Verma R, Glenn M, Maslak P, Rahman ZU, Keenan JR, Weiss M, Filippa D, Zelenetz AD.
    Blood; 2001 Apr 01; 97(7):1929-36. PubMed ID: 11264154
    [Abstract] [Full Text] [Related]

  • 3. Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysis.
    Robertson LE, Huh YO, Butler JJ, Pugh WC, Hirsch-Ginsberg C, Stass S, Kantarjian H, Keating MJ.
    Blood; 1992 Jul 01; 80(1):29-36. PubMed ID: 1377051
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical significance in detection of immunoglobulin heavy chain clonal rearrangement in bone marrow of patients with B cell lymphoma].
    Chen ZY, Zhou XY, Zhang TM, Hong XN, Yin JL, Hu XC, Shi DR.
    Zhonghua Zhong Liu Za Zhi; 2009 Mar 01; 31(3):183-8. PubMed ID: 19615255
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Novel flow-cytometric analysis based on BCD5+ subpopulations for the evaluation of minimal residual disease in chronic lymphocytic leukaemia.
    Maloum K, Sutton L, Baudet S, Laurent C, Bonnemye P, Magnac C, Merle-Béral H.
    Br J Haematol; 2002 Dec 01; 119(4):970-5. PubMed ID: 12472575
    [Abstract] [Full Text] [Related]

  • 13. Biclonal chronic lymphocytic leukemia.
    Hsi ED, Hoeltge G, Tubbs RR.
    Am J Clin Pathol; 2000 Jun 01; 113(6):798-804. PubMed ID: 10874880
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Analysis of residual disease in chronic lymphocytic leukemia by flow cytometry.
    Cabezudo E, Matutes E, Ramrattan M, Morilla R, Catovsky D.
    Leukemia; 1997 Nov 01; 11(11):1909-14. PubMed ID: 9369425
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Molecular characterization of chronic lymphocytic leukemia with two distinct cell populations: Evidence for separate clonal origins.
    Chang H, Cerny J.
    Am J Clin Pathol; 2006 Jul 01; 126(1):23-8. PubMed ID: 16753602
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Detection of immunoglobulin gene rearrangement in lymphoid malignancies of B-cell lineage by seminested polymerase chain reaction gene amplification.
    Liang R, Chan V, Chan TK, Wong T, Chiu E, Lie A, Todd D.
    Am J Hematol; 1993 May 01; 43(1):24-8. PubMed ID: 8317459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.